Showing results (121-130 of 143) with videos related to
Sort By:
Pageof 15
International Journal of Cancer|October 10, 2009
p38delta/MAPK13 as a diagnostic marker for cholangiocarcinoma and its involvement in cell motility and invasionFelicia Li-Sher Tan, Aikseng Ooi, Dachuan Huang, et al.Oncogene|October 14, 2003
Molecular subclassification of kidney tumors and the discovery of new diagnostic markersMasayuki Takahashi, Ximing J Yang, Jun Sugimura, et al.Cancer Research|November 20, 2002
Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical featuresMasayuki Takahashi, Ximing J Yang, Todd T Lavery, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2009
Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomyQiang Zhang, Brian T Helfand, Thomas L Jang, et al.European Journal of Nuclear Medicine and Molecular Imaging|February 10, 2025
Utility of 18F-DCFPyL PET for local staging for high or very high risk prostate cancer for patients undergoing radical prostatectomyEric V Li, Edward M Schaeffer, Sai Kaushik Shankar Ramesh Kumar, et al.NPJ Precision Oncology|March 20, 2026
Prediction of molecular subtypes from histology: AI-driven analysis of prostate cancer morphological patterns and therapeutic implicationsRamin Nateghi, Aoran Sun, Hao Dang, et al.Plos One|October 8, 2011
TGF-β regulates DNA methyltransferase expression in prostate cancer, correlates with aggressive capabilities, and predicts disease recurrenceQiang Zhang, Lin Chen, Brian T Helfand, et al.Plos One|November 1, 2008
Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasiaJindong Chen, Kunihiko Futami, David Petillo, et al.The American Journal of Surgical Pathology|May 2, 2015
Diagnosis of Gleason pattern 5 prostate adenocarcinoma on core needle biopsy: an interobserver reproducibility study among urologic pathologistsRajal B Shah, Jianbo Li, Liang Cheng, et al.Cancer Research|April 7, 2019
Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate CancerShangze Li, Ka-Wing Fong, Galina Gritsina, et al.Pageof 15